Monday, 30 March 2015
Last updated 7 hours ago
Sep 1 2011 | 10:48am ET
New York-based investment management firm OrbiMed Advisors has closed a new $600 million healthcare fund.
The Luxembourg-domiciled Royal Opportunities fund will invest worldwide in healthcare royalty streams and provide structured debt capital to healthcare companies. Investors in the fund include endowments, foundations and financial institutions.
OrbiMed has tapped three partners—Samuel D. Isaly, Sven H. Borho and W. Carter Neild—along with a dedicated team of four to oversee the fund.
“Life sciences companies are typically dependent on equity markets to raise new capital,” said Tadd Wessel, a managing director on the Royalty Opportunities team. “With this fund, OrbiMed can offer a minimally dilutive capital alternative to fund product launches, M&A opportunities, new product research, and general corporate purposes.”
OrbiMed, which focuses exclusively on the healthcare sector, has over $5 billion in assets under management. The firm employs over 50 professionals in offices in New York, San Francisco, Shanghai, Mumbai and Israel.
Mar 9 2015 | 6:35am ET
As more investors look to diversify, many are beginning to use retirement funds to invest in alternative assets such as private equity and real estate. Kelly Rodriques, CEO & President of PENSCO Trust Company, explains how companies can connect with those looking to use their retirement accounts in a different way. Read more…
Mar 20 2015 | 12:45pm ET
StreetWise Partners, a non-profit organization that works with low-income individuals to help them overcome employment barriers, raised over $275,000 at the 2015 Raising the Ante Charity Poker Tournament and Casino Event last Wednesday evening at Capitale. Here are some photos from the event. Read more…